Cormorant Asset Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-10,000
| Closed | -$824K | – | 108 |
|
|
2021
Q1 | $824K | Hold |
10,000
| – | – | 0.02% | 109 |
|
|
2020
Q4 | $909K | Sell |
10,000
-5,000
| -33% | -$455K | 0.02% | 94 |
|
|
2020
Q3 | $600K | Sell |
15,000
-35,000
| -70% | -$1.4M | 0.02% | 86 |
|
|
2020
Q2 | $1.72M | Sell |
50,000
-25,000
| -33% | -$858K | 0.07% | 75 |
|
|
2020
Q1 | $1.67M | Buy |
+75,000
| New | +$1.67M | 0.08% | 67 |
|